Semax + Selank — Two Neuropeptides.
One Nasal Spray.

Semax

• Increases brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF)
• Enhances long-term potentiation — the cellular mechanism of learning and memory
• Modulates dopaminergic and serotonergic neurotransmission
• Neuroprotective under hypoxic and ischemic conditions
• Rapid nasal absorption — bypasses blood-brain barrier via olfactory pathway

Selank

• Modulates GABA-A receptor sensitivity — anxiolytic without sedation or dependency
• Stabilizes serotonin metabolism and enkephalin degradation
• Normalizes HPA axis tone — reduces cortisol dysregulation from chronic stress
• Gut-brain axis: tuftsin heritage connects to vagal and enteric nervous system signaling
• Anxiolytic with a clean cognitive profile — does not impair attention or memory

Semax: BDNF Upregulation and Neuroplasticity

Brain-derived neurotrophic factor (BDNF) is the primary growth factor responsible for neuronal survival, synaptic plasticity, and the formation of new neural connections. Low BDNF is associated with depression, cognitive decline, poor stress resilience, and reduced capacity for learning. Semax is one of the most potent BDNF-upregulating compounds available — it increases BDNF and NGF expression in the hippocampus and prefrontal cortex, enhancing long-term potentiation (the cellular basis of learning and memory consolidation). The effect is not stimulant-like — it is increasing the brain's structural capacity for cognitive work.

Semax: Dopaminergic and Serotonergic Modulation

Semax also modulates the dopamine and serotonin systems — increasing dopaminergic tone in prefrontal circuits associated with working memory, executive function, and motivation, while stabilizing serotonergic signaling in circuits associated with mood and stress response. This dual neurotransmitter modulation contributes to Semax's profile as a compound that improves cognitive performance without the focus-narrowing or post-dose crashes associated with stimulant approaches.

Selank: GABAergic Anxiolysis Without Sedation

Selank modulates GABA-A receptor sensitivity — the same receptor system targeted by benzodiazepines — but with a markedly different clinical profile. Benzodiazepines broadly potentiate GABA-A activity, producing sedation, impaired cognition, and physical dependency. Selank modulates the system more selectively, reducing anxiety and physiological stress responses without the sedation, cognitive blunting, or dependency liability. Patients remain alert, focused, and cognitively intact — the anxiety is reduced, but the mental sharpness is preserved or improved.

Selank: HPA Axis Normalization and Serotonin Stability

Chronic stress produces two interconnected problems: HPA axis dysregulation (cortisol that is too high, poorly timed, or both) and serotonin system instability (mood volatility, anxiety sensitization, and poor stress recovery). Selank addresses both. It normalizes HPA tone — reducing the excess cortisol output that drives anxiety, sleep disruption, and cognitive impairment — and stabilizes serotonin metabolism by reducing the enzymatic degradation of enkephalins, endogenous opioid peptides that modulate serotonin signaling.

Selank: Gut-Brain Axis

Selank is derived from tuftsin — an endogenous tetrapeptide with established roles in both immune regulation and gut-brain signaling. The gut-brain axis operates via the vagus nerve and the enteric nervous system, and dysregulation of this axis is now recognized as a contributor to anxiety, mood instability, and cognitive fog. Selank's tuftsin heritage gives it signaling activity in this system — relevant for patients whose anxiety, sleep disruption, or cognitive symptoms have a gut-brain component.

The Combination Logic

Semax improves the brain's capacity for high-level cognitive function — more BDNF, better synaptic plasticity, improved neurotransmitter tone. Selank removes the anxiety, HPA dysregulation, and stress-driven interference that prevent that capacity from being fully expressed. Cognitive performance requires both sufficient neuroplasticity and sufficient psychological regulation. The combination targets both simultaneously — which is why the two compounds together produce a more complete clinical effect than either one alone.

Semax's BDNF upregulation and dopaminergic modulation produce improvements in working memory, processing speed, and sustained focus. These are capacity improvements — the brain is better equipped for demanding cognitive work, not artificially stimulated into alertness.

Selank's GABAergic modulation reduces anxiety and physiological stress responses without the sedation, cognitive blunting, or dependency risks of benzodiazepines. Patients who need to be cognitively sharp while managing anxiety find this particularly valuable.

Patients under chronic high cognitive or psychological load often present with flattened stress response curves, persistent HPA dysregulation, and the cognitive and emotional symptoms that follow. Selank's HPA normalization directly addresses the physiological substrate of these patterns.

Serotonin system stabilization via Selank produces a steadier emotional floor rather than a mood lift — less volatility, better recovery from stressors, improved baseline wellbeing without the peaks and troughs of stimulant or anxiolytic cycles.

For patients whose cognitive fog, anxiety, or mood symptoms have a gut-brain origin — dysbiosis, vagal tone dysregulation, or enteric nervous system disruption — Selank's tuftsin-derived signaling addresses a mechanism that most neurologically-focused compounds miss entirely.

Selank's HPA normalization and anxiety reduction have downstream effects on sleep. Patients whose primary sleep barrier is evening cortisol elevation, racing thoughts, or stress-sensitized arousal often see meaningful sleep improvement from Selank's stress-regulatory effects alone.

High-Cognitive-Load Professionals with Anxiety

Executives, clinicians, attorneys, engineers — anyone operating in sustained high-demand cognitive environments where anxiety or stress is also present. Conventional options force a choice: stimulants improve focus but worsen anxiety; anxiolytics reduce anxiety but blunt cognition. The Semax/Selank combination addresses both simultaneously.

Patients with Stress-Driven Cognitive Fog

Patients who are intelligent and capable but feel they are operating below their cognitive ceiling — not because of a structural deficit, but because chronic stress, anxiety, or HPA dysregulation is degrading working memory, processing speed, and executive function. Selank removes the interference; Semax upgrades the underlying hardware.

The Patient Coming Off Benzodiazepines or Anxiolytics

Patients who have used pharmaceutical anxiolytics and want a non-dependency-forming alternative for ongoing anxiety management. Selank's GABAergic mechanism provides anxiolytic effect without the receptor downregulation, tolerance, or withdrawal that define benzodiazepine dependence. Should be managed in coordination with the prescribing provider.

Sleep-Disrupted Patients with Anxiety-Driven Waking

Patients whose primary sleep problem is anxiety-driven — racing thoughts at sleep onset, cortisol-driven early waking, stress-sensitized arousal — rather than architectural poor sleep. For this pattern, Selank's stress regulation and HPA normalization address the root cause more directly than sleep-specific peptides like DSIP.

Patients with Gut-Brain Axis Involvement

Patients who have noticed that their anxiety, mood, or cognitive clarity tracks with gut health — or who have been advised that gut-brain axis dysregulation may be a contributing factor — will benefit from Selank's tuftsin-derived gut-brain signaling alongside its central anxiolytic effects.

Patients Seeking Cognitive Longevity

BDNF is neuroprotective — it supports neuronal survival and resilience against age-related decline in synaptic plasticity. Patients using Semax/Selank as part of a long-range cognitive longevity protocol (alongside Epithalon or NAD+) benefit from Semax's consistent BDNF upregulation over time.

Formulation

Semax/Selank 2.5mg/2.5mg per mL nasal spray. Both compounds are delivered simultaneously in each spray — dose titration adjusts both proportionally. Nasal delivery bypasses first-pass metabolism and provides direct CNS access via the olfactory pathway.

Typical Dose

One to two sprays per nostril, one to two times daily. Dosing is typically lower in the morning (cognitive activation without excess stimulation) and can be repeated midday if sustained cognitive demand is anticipated. Your provider will establish the specific dose appropriate for your protocol.

Timing

Morning dosing takes advantage of Semax's neurotrophic and dopaminergic effects during peak cognitive demand hours. For anxiety-predominant patients, dosing can be timed around predictable high-stress windows. For sleep-disrupted patients, evening dosing may leverage Selank's HPA normalization during the cortisol drawdown period before bed.

Cycle Structure

Semax/Selank can be used in defined cycles (10–14 days on, several days off) or on a consistent daily basis depending on the clinical indication. Because neither compound carries dependency liability, cycling is a preference and protocol choice rather than a medical necessity.

Stacking Considerations

For sleep-disrupted patients, Selank pairs well with DSIP (DSIP addresses sleep architecture; Selank addresses the upstream anxiety). For cognitive longevity, Semax/Selank complements Epithalon (BDNF alongside telomere maintenance) and NAD+ (synaptic function alongside cellular energy). Your provider will advise on appropriate combinations.

Semax / Selank 2.5mg / 2.5mg per mL — Nasal Spray

BDNF-driven cognitive enhancement and GABAergic anxiolysis in a single daily delivery. Nasal absorption provides direct CNS access via the olfactory pathway. No injections required.

$279.00

Intranasal Spray

• Async telehealth provider consultation
• Prescription fulfillment through Optimal Balance Pharmacy
• FedEx Standard Overnight shipping